Galen Vitale
Biology & Medicine · Science
Dasatinib: four responses do not yet define who should receive it
Columns
- Dasatinib: four responses do not yet define who should receive it
- A particle stays in the tumour; the dose question reaches toward patients
- How much do Blastocystis subtypes explain bowel pain?
- The risk blood tests describe in gastric cancer
- RAD51D map narrows uncertain genetic results
- Separate traces of aging and Alzheimer's in brain connectivity
- A new route to fetal haemoglobin remains far from patients
- The early story told by a protein in the gut
- Lithium’s WDFY3 result is in cells; families await human evidence
- A 15-minute blood-pressure gap in the emergency department
- The 10-15 per cent GLP-1 drugs barely move
- The Sahel is the denominator for 239,000 extra heat deaths
- Personalized phage therapy has a roadmap before it has strong evidence
- Microbiome timing in type 1 diabetes risk
- Bangladesh measles counts make the cost of vaccination gaps visible again
- Salmonella ST34 spread by losing dinB, then fljB
- The 15.6 percent in the high-risk arm sets the denominator
- Ontario and Quebec's free nirsevimab offer reached infants without a comorbidity filter
- Where does chronic loneliness show up across 17 health outcomes?
- What the brain loses when the task is uncertain
- Sst-Chodl neurons put mice to sleep, supplying the intervention human studies lack
- The embryo that took every edit
- Appendix cancer's chemotherapy question rests on 19 relapses
- Every PCSK9 allele was edited; the bystander sites stayed mosaic
- Sixteen patients, one blood test, and the distance to the clinic
- Menopause shows up in the cortex as an absence of loss, measured in 120 women
- Paracetamol's headline percentages come from two separate exposure windows in the same cohort
- The ESR1 mutation in blood moved the switch forward; the survival question stayed put
- Layer 6b silencing left the hours of sleep intact and thinned its depth
- Cerebellar volume fell with age and cerebellar timing did not